Skip to main content

Base4 Bioinformatics Elects Miller, Pearson to Board


MISSISSAUGA, Ont.--Base4 Bioinformatics announced that it has appointed Mark Pearson and Susan Miller to its board of directors. Miller's experience in the personal computer industry includes positions as president of Compaq Canada, as founding president of Tallgrass Canada, and in executive management at Merisel in Canada and Europe. Pearson is a former president of Molecumetics in Seattle.

Martin Sumner-Smith, president and CEO of Base4, said, "Pearson represents a strategic addition to the board to provide guidance as Base4 expands into the US market. His insights into the convergence of electronic and information technologies as they will apply to the pharmaceutical and biotechnology industries will assist in positioning Base4 as a leading supplier to this sector."

Filed under

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.